Table 1 The baseline characteristics of participants.
ALT/HDL-C ratio | Q1 (≤ 7.971) | Q2 (7.971–11.602) | Q3 (11.602–17.419) | Q4 (> 17.419) | P-value |
---|---|---|---|---|---|
Participants | 2994 | 2992 | 2995 | 2994 | |
Gender | < 0.001 | ||||
Female | 1485 (49.599%) | 1366 (45.655%) | 1311 (43.773%) | 1257 (41.984%) | |
Male | 1509 (50.401%) | 1626 (54.345%) | 1684 (56.227%) | 1737 (58.016%) | |
Age (years) | 43.048 ± 15.103 | 43.308 ± 15.080 | 43.803 ± 15.126 | 42.955 ± 14.439 | 0.121 |
SBP (mmHg) | 117.895 ± 17.484 | 121.505 ± 17.128 | 124.473 ± 16.762 | 125.592 ± 15.250 | < 0.001 |
DBP (mmHg) | 70.888 ± 10.001 | 72.938 ± 10.181 | 75.030 ± 10.468 | 76.221 ± 10.057 | < 0.001 |
BMI (kg/m2) | 20.558 ± 1.992 | 21.294 ± 1.987 | 21.947 ± 1.888 | 22.597 ± 1.693 | < 0.001 |
ALT (IU/L) | 10.638 ± 2.606 | 14.599 ± 3.096 | 19.147 ± 4.362 | 31.681 ± 12.150 | < 0.001 |
AST (IU/L) | 18.656 ± 3.769 | 20.650 ± 4.087 | 22.798 ± 5.070 | 27.995 ± 9.244 | < 0.001 |
GGT (IU/L) | 17 (14, 21) | 19 (15, 25) | 24 (19, 32) | 32 (23, 49) | < 0.001 |
ALP (IU/L) | 64.070 ± 18.515 | 70.090 ± 23.773 | 74.476 ± 21.831 | 79.954 ± 24.511 | < 0.001 |
HDL-C (mmol/L) | 1.732 ± 0.332 | 1.512 ± 0.296 | 1.352 ± 0.286 | 1.209 ± 0.279 | < 0.001 |
TG (mmol/L) | 0.90 (0.71, 1.140) | 1.05 (0.81, 1.38) | 1.25 (0.95, 1.69) | 1.55 (1.13, 2.23) | < 0.001 |
TC (mmol/L) | 4.671 ± 0.725 | 4.599 ± 0.720 | 4.566 ± 0.729 | 4.593 ± 0.759 | < 0.001 |
LDL-C (mmol/L) | 2.202 ± 0.466 | 2.269 ± 0.473 | 2.295 ± 0.463 | 2.324 ± 0.473 | < 0.001 |
FPG (mmol/L) | 5.063 ± 0.625 | 5.182 ± 0.737 | 5.266 ± 0.874 | 5.332 ± 0.997 | < 0.001 |
UA (μmol/L) | 254.902 ± 85.821 | 279.791 ± 87.351 | 306.818 ± 84.356 | 330.421 ± 81.953 | < 0.001 |
Cr (μmol/L) | 77.433 ± 23.385 | 81.962 ± 24.191 | 86.806 ± 30.280 | 87.599 ± 20.240 | < 0.001 |
ALT/HDL-C ratio | 6.196 ± 1.227 | 9.682 ± 1.043 | 14.218 ± 1.694 | 26.426 ± 8.426 | < 0.001 |